Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Building better biobetters: From fundamentals to industrial application

Full text
Author(s):
Torres-Obreque, Karin M. [1] ; Meneguetti, Giovanna P. [1, 2] ; Muso-Cachumba, Jorge J. [1] ; Feitosa, Valker A. [1, 2] ; Santos, Joao H. P. M. [1, 3] ; Ventura, Sonia P. M. [3] ; Rangel-Yagui, Carlota O. [1]
Total Authors: 7
Affiliation:
[1] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Biochem & Pharmaceut Technol, Sao Paulo - Brazil
[2] Inst Technol Res IPT, Bionanomfg Ctr, Sao Paulo - Brazil
[3] Univ Aveiro, Dept Chem, CICECO Aveiro Inst Mat, Aveiro - Portugal
Total Affiliations: 3
Document type: Review article
Source: DRUG DISCOVERY TODAY; v. 27, n. 1, p. 65-81, JAN 2022.
Web of Science Citations: 0
Abstract

Biological drugs or biopharmaceuticals off patent open a large market for biosimilars and biobetters, follow-on biologics. Biobetters, in particular, are new drugs designed from existing ones with improved properties such as higher selectivity, stability, half-life and/or lower toxicity/immunogenicity. Glycosylation is one of the most used strategies to improve biological drugs, nonetheless bioconjugation is an additional alternative and refers to the covalent attachment of polymers to biological drugs. Extensive research on novel polymers is underway, nonetheless PEGylation is still the best alternative with the longest clinical track record. Innovative trends based on genetic engineering techniques such as fusion proteins and PASylation are also promising. In this review, all these alternatives were explored as well as current market trends, legislation and future perspectives. (AU)

FAPESP's process: 16/22065-5 - N-terminal pegylation of proteins and purification by aqueous two-phase systems
Grantee:Carlota de Oliveira Rangel Yagui
Support Opportunities: Regular Research Grants
FAPESP's process: 18/25994-2 - Development of novel platforms for PEGylation of proteins with therapeutic potential using microfluidics
Grantee:João Henrique Picado Madalena Santos
Support Opportunities: Scholarships in Brazil - Post-Doctoral